Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 901-910 of 969 for hematology

Edit search filters
  1. A Study to Evaluate Circulating Tumor Cells from Patients with Treatment-Refractory Advanced Solid Tumors Managed in the Early Cancer Therapeutics Program

  2. A Study to Assess DNA Tumor Markers in Whole Blood Specimens of Patients with Newly Diagnosed Lung Cancer

    Rochester, MN

  3. A Study of the Incidence and Prevalence of Oral Squamous Cell Carcinoma in Patients with Oral Lichen Planus in Olmsted County from 1986-2010.

    Rochester, MN

  4. A Novel Method of Screening for Ovarian Cancer Using Gynecologic Fluids and Mucus

    Rochester, MN

  5. Patient and Caregiver Perspective About Financial Distress of Cancer Treatment

    Scottsdale/Phoenix, AZ

  6. A Study About How Platelets Adhere to the Blood von Willebrand Factor in Healthy Adults

    Rochester, MN

  7. Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia

    Jacksonville, FL, Rochester, MN

  8. A Study of Rose Geranium in Sesame Oil Nasal Spray for Treating Established Chemotherapy and Targeted Therapy-Related Nasal Vestibulitis

    Rochester, MN

  9. Risk Factors Associated with Clustered Plasma Cell Dyscrasias in Minnesota

    Rochester, MN

  10. Response to PD-1 Blockade in Patients with Mismatch Repair Deficient Colorectal Cancer

    Rochester, MN

.

Mayo Clinic Footer